• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

案例报告:涉及羟吗啡酮的死亡案例:两例报告。

Case report: Oxymorphone-involved fatalities: a report of two cases.

机构信息

County of San Diego Medical Examiner's Office, San Diego, California 92123, USA.

出版信息

J Anal Toxicol. 2009 Nov-Dec;33(9):615-9. doi: 10.1093/jat/33.9.615.

DOI:10.1093/jat/33.9.615
PMID:20040137
Abstract

There has been an increased awareness of illicit opiate abusers using the narcotic oxymorphone (Opana) by inhalation. Many laboratory screening techniques currently in use cannot detect oxymorphone in blood or urine. Consequently, biological specimens containing low to moderate concentrations of oxymorphone will likely go undetected. The circumstances, pathology findings, and toxicology results of two fatalities involving oxymorphone are presented. An opiate confirmation gas chromatography-mass spectrometry (GC-MS) procedure, described in detail was able to detected, confirm, and quantify oxymorphone in both subjects. The blood concentrations were 0.05 mg/L (50 microg/L) and 0.12 mg/L (120 microg/L).

摘要

人们越来越意识到,非法阿片类药物滥用者通过吸入的方式来使用麻醉性阿片类药物羟吗啡酮(Opana)。目前许多实验室常用的筛选技术无法检测血液或尿液中的羟吗啡酮。因此,含有低至中等浓度羟吗啡酮的生物样本可能会被漏检。本文介绍了涉及羟吗啡酮的两例死亡事件的情况、病理发现和毒理学结果。详细描述的阿片类药物确证气相色谱-质谱联用(GC-MS)程序能够检测、确认并定量分析两个检材中的羟吗啡酮。血液浓度分别为 0.05 毫克/升(50 微克/升)和 0.12 毫克/升(120 微克/升)。

相似文献

1
Case report: Oxymorphone-involved fatalities: a report of two cases.案例报告:涉及羟吗啡酮的死亡案例:两例报告。
J Anal Toxicol. 2009 Nov-Dec;33(9):615-9. doi: 10.1093/jat/33.9.615.
2
Concentration of oxymorphone in postmortem fluids and tissue.
J Anal Toxicol. 2009 Apr;33(3):121-8. doi: 10.1093/jat/33.3.121.
3
Improved oxymorphone detection in postmortem specimens.死后标本中羟吗啡酮检测的改进。
J Anal Toxicol. 2010 Mar;34(2):112. doi: 10.1093/jat/34.2.112.
4
An overdose death involving the insufflation of extended-release oxymorphone tablets.涉及经鼻吸入缓释羟吗啡酮片的用药过量致死案例。
J Anal Toxicol. 2010 Oct;34(8):521-6. doi: 10.1093/jat/34.8.521.
5
U-47700: A Not So New Opioid.U-47700:一种并非全新的阿片类药物。
J Anal Toxicol. 2018 Jan 1;42(1):e12-e14. doi: 10.1093/jat/bkx081.
6
Forensic drug testing for opiates. VI. Urine testing for hydromorphone, hydrocodone, oxymorphone, and oxycodone with commercial opiate immunoassays and gas chromatography-mass spectrometry.阿片类药物的法医毒物检测。六、使用商用阿片类免疫分析法和气相色谱 - 质谱联用技术对氢吗啡酮、氢可酮、羟吗啡酮和羟考酮进行尿液检测。
J Anal Toxicol. 1995 Jan-Feb;19(1):18-26. doi: 10.1093/jat/19.1.18.
7
GC-MS quantitation of codeine, morphine, 6-acetylmorphine, hydrocodone, hydromorphone, oxycodone, and oxymorphone in blood.血液中可待因、吗啡、6-乙酰吗啡、氢可酮、氢吗啡酮、羟考酮和羟吗啡酮的气相色谱-质谱联用定量分析。
J Anal Toxicol. 2005 Jul-Aug;29(5):301-8. doi: 10.1093/jat/29.5.301.
8
Observed Carfentanil Concentrations in 355 Blood Specimens from Forensic Investigations.法医调查中355份血液样本中观察到的卡芬太尼浓度。
J Anal Toxicol. 2017 Nov 1;41(9):777-778. doi: 10.1093/jat/bkx068.
9
Illicit Fentanyl-Related Fatalities in Florida: Toxicological Findings.佛罗里达州与非法芬太尼相关的死亡案例:毒理学调查结果
J Anal Toxicol. 2016 Oct;40(8):588-594. doi: 10.1093/jat/bkw087.
10
Case Report of Methylone, Oxymorphone and Ethanol in a Fatality Case with Tissue Distribution.
J Anal Toxicol. 2016 Sep;40(7):543-5. doi: 10.1093/jat/bkw045. Epub 2016 Jul 11.

引用本文的文献

1
Opana ER (Oxymorphone)-Induced Thrombotic Microangiopathy: An Atypical Presentation in a Patient With Hepatitis C.奥施康定ER(羟吗啡酮)诱发的血栓性微血管病:1例丙型肝炎患者的非典型表现
J Investig Med High Impact Case Rep. 2018 Jan 31;6:2324709618756423. doi: 10.1177/2324709618756423. eCollection 2018 Jan-Dec.
2
Pharmacodynamic effects of oral oxymorphone: abuse liability, analgesic profile and direct physiologic effects in humans.口服羟吗啡酮的药效学效应:人体中的滥用可能性、镇痛特征及直接生理效应
Addict Biol. 2016 Jan;21(1):146-58. doi: 10.1111/adb.12173. Epub 2014 Jul 31.
3
Assessment of a formulation designed to be crush-resistant in prescription opioid abusers.
评估一种旨在防止处方类阿片滥用者压碎的配方。
Drug Alcohol Depend. 2012 Nov 1;126(1-2):206-15. doi: 10.1016/j.drugalcdep.2012.05.013. Epub 2012 Jun 20.